Injectable ketorolac tromethamine recalled nationwide for potential cross-contamination
Nephron Pharmaceuticals is recalling Ketorolac Tromethamine Injection due to manufacturing deviations that could lead to cross-contamination. The recall affects 5,040 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for an injectable pharmaceutical with potential cross-contamination resulting from manufacturing deviations. While no illnesses or injuries have been reported, injectable products with manufacturing defects present a risk of harm.
Plain-English summary
Ketorolac Tromethamine Injection, USP (60 mg/2 mL) manufactured by Nephron Pharmaceuticals Corporation is being recalled. The affected product is packaged in 2 mL single-dose vials with lot number 023011 (expiration date August 31, 2022).
The recall is due to cGMP deviations that could lead to potential cross-contamination. The FDA has classified this as a Class II recall.
The recall affects 5,040 vials distributed nationwide.
The recalled product
- Product
- KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Nephron Sc Inc
- Category
- Drug — Injectable
- Hazard
- cross-contamination
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot#: 023011 Exp 8/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · KETOROLAC TROMETHAMINE
- SevereKetorolac Tromethamine Ophthalmic Solution Recalled for Sterility Risk
FDA (Drugs) · 2025-07-02
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22